RP Bio Inc. (KOSDAQ:314140)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,950.00
+270.00 (4.75%)
At close: Jul 31, 2026

RP Bio Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
13,2539,84814,1333,20816,8166,269
Short-Term Investments
8,7753,7774,7029,3501,4881,449
Trading Asset Securities
1,0091,002----
Cash & Short-Term Investments
23,03714,62618,83612,55818,3047,718
Cash Growth
27.59%-22.35%49.99%-31.39%137.16%-16.89%
Accounts Receivable
17,01918,49917,65919,99520,77321,320
Other Receivables
-111.4738.22353.66332.09112.17
Receivables
17,01918,61117,99720,34921,70521,433
Inventory
26,27124,13723,96234,10938,59022,569
Prepaid Expenses
-35.81212.71162.67177.3674.56
Other Current Assets
555.72171.39104.95535.722,266477.83
Total Current Assets
66,88357,58161,11267,71481,04352,272
Property, Plant & Equipment
93,09294,33695,92196,97588,72788,970
Long-Term Investments
66.0966.0966.0966.0966.0966.09
Other Intangible Assets
795.56756.47495.5335.15453.91538.48
Long-Term Deferred Tax Assets
1,3241,324741.131.49-318.05
Other Long-Term Assets
2,5292,1641,1331,0962,7981,573
Total Assets
164,690156,256159,499166,218173,158143,737

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
24,05919,42917,33020,73729,78124,529
Accrued Expenses
-1,9271,3341,7412,0101,779
Short-Term Debt
19,23516,00025,00025,00034,87336,826
Current Portion of Leases
256.76309.07601.391,007676.85651.95
Current Income Taxes Payable
232.5446.11252.0725.14710.76218.3
Other Current Liabilities
6,2556,2946,6588,98610,5797,385
Total Current Liabilities
50,03944,40451,17557,49678,63071,389
Long-Term Leases
3,0673,1394,5934,7742,6352,858
Pension & Post-Retirement Benefits
1,706983.57912.89616.03--
Long-Term Deferred Tax Liabilities
----237.08-
Other Long-Term Liabilities
554.32531.73515.29584.61519.18501.27
Total Liabilities
55,36649,05857,19663,47182,02174,748

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
4,3334,3334,3334,3334,0973,294
Additional Paid-In Capital
65,34965,34965,34965,34658,82637,431
Retained Earnings
39,70537,57932,68433,12828,26824,160
Treasury Stock
-81.47-81.47-81.47-81.47-81.47-81.47
Comprehensive Income & Other
17.8817.8817.8821.5627.33123.52
Total Common Equity
109,324107,198102,303102,74791,13764,927
Shareholders' Equity
109,324107,198102,303102,74791,13768,989
Total Liabilities & Equity
164,690156,256159,499166,218173,158143,737

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
22,55919,44830,19430,78138,18540,336
Net Cash (Debt)
478.15-4,821-11,359-18,223-19,881-32,618
Net Cash Growth
------
Net Cash Per Share
55.28-557.39-1314.76-1950.62-2791.65-4962.17
Filing Date Shares Outstanding
8.658.658.658.658.186.57
Total Common Shares Outstanding
8.658.658.658.658.186.57
Working Capital
16,84413,1779,93710,2182,413-19,117
Book Value Per Share
12638.8312393.0311827.1611878.4311145.289877.25
Tangible Book Value
108,528106,441101,808102,41190,68364,388
Tangible Book Value Per Share
12546.8512305.5811769.8811839.6811089.779795.34
Land
17,33317,33315,44115,44115,44115,441
Buildings
63,55563,55562,86657,48756,36755,187
Machinery
49,40849,34255,98554,55846,90444,016
Construction In Progress
916.33671.567982,264832.74523.48